This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) rallied 1.96% to $2.08 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.54% to 26,270.36 and the Dow Jones Industrial Average rising 1.31% to 50,009.35.
This was the stock's fourth consecutive day of gains.
TherapeuticsMD Inc. closed 29.49% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock outperformed some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 0.68% to $212.30.
Trading volume (10,068) remained 11,924 below its 50-day average volume of 21,992.
Data source: Dow Jones Market Data, FactSet. Data compiled May 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-20-26 1729ET

TXMD

SBIO

TherapeuticsMD Inc. (TXMD) shares rose 1.96% to $2.08 on a strong trading day, marking the fourth consecutive day of gains. The NASDAQ Composite Index increased by 1.54%, while the Dow Jones Industrial Average rose 1.31%. TXMD remains 29.49% below its 52-week high of $2.95. In contrast, competitor AbbVie Inc. (ABBV) fell 0.68% to $212.30. Trading volume was below the 50-day average.

MarketWatch Automated

Therapeutics MD

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

iShares Global Healthcare

Ark Genomic Revolution ETF

iShares Biotechnology ETF

VG Health

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

iShares US Pharma

NASDAQ Composite Index

Dow Jones Industrial Average

Abbvie

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day